Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

10.25
Delayed Data
As of Aug 26
 +0.05 / +0.49%
Today’s Change
4.37
Today|||52-Week Range
10.85
+64.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues558.0K45.6M105.4M118.8M
 
 
 
 
 
Cost of Goods Sold--5.5M817.0K1.5M
 
 
 
 
Depreciation And Amortization3.0M4.1M8.8M12.8M
 
 
 
 
 
 
Operating ExpensesGross Income--35.9M95.8M104.6M
 
 
 
 
General Expenses197.8M304.7M256.0M321.2M
 
 
 
 
 
Other Operating Expenses0.000.000.00615.0K
 
 
Research And Development139.9M160.7M120.6M171.2M
 
 
 
 
 
Total Operating Expenses200.8M314.3M265.6M336.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-200.3M-268.8M-160.2M-217.3M
 
 
 
 
 
Extraordinary Credit0.000.004.8M0.00
 
 
Extraordinary Charge-20.7M-4.8M0.000.00
 
 
 
Interest Expense On Debt199.0K153.0K8.1M18.1M
 
 
 
 
 
Other Expenses71.0K-130.0K1.4M793.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-220.9M-273.7M-162.0M-234.6M
 
 
 
 
 
Income Taxes0.00-439.0K-630.0K-3.4M
 
 
 
 
Net Income-220.9M-274.2M-162.6M-231.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS165.0M183.6M186.8M188.7M
 
 
 
 
 
Shares To Calculate EPS Diluted165.0M183.6M186.8M188.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.34-$1.49-$0.87-$1.23
 
 
 
 
 
EPS Diluted-$1.34-$1.49-$0.87-$1.23